Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Dynavax Technologies

Dynavax Technologies Stock Sees Renewed Technical Strength

Dynavax Technologies shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 84.

Investors Business Daily

Dynavax Technologies Stock Clears Key Benchmark, Hitting 80-Plus RS Rating

Dynavax Technologies Stock Clears Key Benchmark, Hitting 80-Plus RS Rating

Dynavax Technologies sees its Relative Strength Rating enter the 80-plus level.

Investors Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

12 Health Care Stocks Moving In Thursday's After-Market Session

Dynavax Technologies Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q4, Dynavax Technologies (NASDAQ:DVAX) earned $99.78 million, a 450.96% increase from the preceding quarter. Dynavax Technologies also posted a total of $195.07 million in sales, a 80.17% increase since Q3.

Recap: Dynavax Technologies Q4 Earnings

Dynavax Technologies (NASDAQ:DVAX) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Dynavax Technologies Stock Sees Relative Strength Rating Rise To 85

Dynavax Technologies sees its Relative Strength Rating move into the 80-plus level.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

A Preview Of Dynavax Technologies's Earnings

A Preview Of Dynavax Technologies's Earnings

Dynavax Technologies (NASDAQ:DVAX) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts estimate that Dynavax Technologies will report an earnings per share (EPS) of $0.69.

1

Organisations

Evercore ISI Group

Keurig Dr Pepper

Core Scientific

Cincinnati Financial

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play